Related Experiment Videos

Endocrine causes of secondary hypertension

Domenic A Sica1

  • 1Virginia Commonwealth University Health System, Richmond, VA 23298-0160, USA. dsica@mcvh-vcu.edu

Journal of Clinical Hypertension (Greenwich, Conn.)
|July 9, 2008
PubMed

Insights

Secondary hypertension, often caused by endocrine disorders, requires thorough evaluation. Primary aldosteronism is a frequent endocrine cause, and identifying it can lead to improved blood pressure management.

Area of Science:

  • Endocrinology
  • Nephrology
  • Internal Medicine

Background:

  • Secondary hypertension is prevalent, with endocrine disorders presenting diverse patterns like new-onset or uncontrolled blood pressure.
  • A detailed patient history and physical examination are crucial for identifying potential endocrine causes of hypertension.

Purpose of the Study:

  • To highlight the significance of identifying endocrine causes of secondary hypertension.
  • To emphasize primary aldosteronism as a common and treatable endocrine etiology of difficult-to-manage hypertension.

Main Methods:

  • Review of clinical presentations of endocrine hypertension.
  • Discussion of diagnostic prerequisites including patient history and physical examination.
  • Comparative analysis of the frequency of different endocrine causes.

Main Results:

  • While pheochromocytoma and Cushing's disease are rare, primary aldosteronism is a frequent endocrine cause of secondary hypertension.
  • Hypokalemia, a potential hallmark of primary aldosteronism, can be inconsistently present, complicating diagnosis.

Conclusions:

  • Identifying endocrine causes of hypertension is critical as surgical intervention can resolve or significantly improve the condition.
  • Primary aldosteronism should be a primary consideration in patients with resistant or difficult-to-treat hypertension.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...